These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30279372)

  • 1. Assay Challenges for Emerging Infectious Diseases: The Zika Experience.
    Roberts CC; Maslow JN
    Vaccines (Basel); 2018 Oct; 6(4):. PubMed ID: 30279372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development.
    Roberts CC
    Hum Vaccin Immunother; 2019; 15(10):2258-2263. PubMed ID: 31268394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease.
    Collins MH
    Trop Med Infect Dis; 2019 Apr; 4(2):. PubMed ID: 31010134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
    Maslow JN
    Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus.
    Kudchodkar SB; Choi H; Reuschel EL; Esquivel R; Jin-Ah Kwon J; Jeong M; Maslow JN; Reed CC; White S; Kim JJ; Kobinger GP; Tebas P; Weiner DB; Muthumani K
    Microbes Infect; 2018 Dec; 20(11-12):676-684. PubMed ID: 29555345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping time use in clinical trials for vaccines against emerging infectious diseases.
    Mandi H; Yimer SA; Norheim G
    Clin Trials; 2021 Jun; 18(3):286-294. PubMed ID: 33653146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zika Virus Vaccine Development.
    Morabito KM; Graham BS
    J Infect Dis; 2017 Dec; 216(suppl_10):S957-S963. PubMed ID: 29267918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Zika Virus Vaccines.
    Garg H; Mehmetoglu-Gurbuz T; Joshi A
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30441757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zika virus: An emerging infectious disease with serious perinatal and neurologic complications.
    Casale TB; Teng MN; Morano JP; Unnasch T; Lockwood CJ
    J Allergy Clin Immunol; 2018 Feb; 141(2):482-490. PubMed ID: 29273403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
    Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
    Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development.
    Castanha PMS; Marques ETA
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33266129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans.
    Burgomaster KE; Foreman BM; Aleshnick MA; Larman BC; Gordon DN; Maciejewski S; Morabito KM; Ledgerwood JE; Gaudinski MR; Chen GL; Mascola JR; Debbink K; Dowd KA; Graham BS; Pierson TC
    J Infect Dis; 2021 Nov; 224(9):1550-1555. PubMed ID: 33961055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Zika Virus Infection by Peptide Array and Enzyme-Linked Immunosorbent Assay.
    Mishra N; Caciula A; Price A; Thakkar R; Ng J; Chauhan LV; Jain K; Che X; Espinosa DA; Montoya Cruz M; Balmaseda A; Sullivan EH; Patel JJ; Jarman RG; Rakeman JL; Egan CT; Reusken CBEM; Koopmans MPG; Harris E; Tokarz R; Briese T; Lipkin WI
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for Zika virus infection in pregnancy: key concepts to deal with an emerging epidemic.
    Eppes C; Rac M; Dunn J; Versalovic J; Murray KO; Suter MA; Sanz Cortes M; Espinoza J; Seferovic MD; Lee W; Hotez P; Mastrobattista J; Clark SL; Belfort MA; Aagaard KM
    Am J Obstet Gynecol; 2017 Mar; 216(3):209-225. PubMed ID: 28126366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil.
    Zanotto PMA; Leite LCC
    Front Immunol; 2018; 9():1964. PubMed ID: 30210503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse outcomes of pregnancy-associated Zika virus infection.
    Britt WJ
    Semin Perinatol; 2018 Apr; 42(3):155-167. PubMed ID: 29523447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory Diagnosis of Zika Virus Infection.
    Landry ML; St George K
    Arch Pathol Lab Med; 2017 Jan; 141(1):60-67. PubMed ID: 27763787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.